Literature DB >> 1684089

Presymptomatic detection or exclusion of prion protein gene defects in families with inherited prion diseases.

J Collinge1, M Poulter, M B Davis, M Baraitser, F Owen, T J Crow, A E Harding.   

Abstract

The identification of defects in the prion protein (PrP) gene in families with inherited Creutzfeldt-Jakob disease or Gerstmann-Straussler syndrome allows presymptomatic diagnosis or exclusion of these disorders in subjects at risk. After counseling, PrP gene analysis was performed in three such individuals: two from families with a 144-bp insert and one with a point mutation at codon 102 in the PrP gene. The presence of a PrP gene defect was confirmed in one and excluded in two. Despite the potential problems of using PrP gene analysis in genetic prediction - specifically, uncertainty about penetrance and, generally, problems of presymptomatic testing in any inherited late-onset neurodegenerative disorder - we conclude that it has a role to play in improved genetic counseling for families with inherited prion diseases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684089      PMCID: PMC1686464     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  16 in total

1.  Uptake of presymptomatic predictive testing for Huntington's disease.

Authors:  D Craufurd; A Dodge; L Kerzin-Storrar; R Harris
Journal:  Lancet       Date:  1989-09-09       Impact factor: 79.321

2.  Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome.

Authors:  D Goldgaber; L G Goldfarb; P Brown; D M Asher; W T Brown; S Lin; J W Teener; S M Feinstone; R Rubenstein; R J Kascsak
Journal:  Exp Neurol       Date:  1989-11       Impact factor: 5.330

3.  Insertion in prion protein gene in familial Creutzfeldt-Jakob disease.

Authors:  F Owen; M Poulter; R Lofthouse; J Collinge; T J Crow; D Risby; H F Baker; R M Ridley; K Hsiao; S B Prusiner
Journal:  Lancet       Date:  1989-01-07       Impact factor: 79.321

4.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

5.  Pro----leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Sträussler syndrome.

Authors:  K Doh-ura; J Tateishi; H Sasaki; T Kitamoto; Y Sakaki
Journal:  Biochem Biophys Res Commun       Date:  1989-09-15       Impact factor: 3.575

Review 6.  Unraveling prion diseases through molecular genetics.

Authors:  D Westaway; G A Carlson; S B Prusiner
Journal:  Trends Neurosci       Date:  1989-06       Impact factor: 13.837

7.  Diagnosis of Gerstmann-Sträussler syndrome in familial dementia with prion protein gene analysis.

Authors:  J Collinge; A E Harding; F Owen; M Poulter; R Lofthouse; A M Boughey; T Shah; T J Crow
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

8.  Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome.

Authors:  K Hsiao; H F Baker; T J Crow; M Poulter; F Owen; J D Terwilliger; D Westaway; J Ott; S B Prusiner
Journal:  Nature       Date:  1989-03-23       Impact factor: 49.962

9.  Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies.

Authors:  C L Masters; D C Gajdusek; C J Gibbs
Journal:  Brain       Date:  1981-09       Impact factor: 13.501

10.  Spontaneous neurodegeneration in transgenic mice with mutant prion protein.

Authors:  K K Hsiao; M Scott; D Foster; D F Groth; S J DeArmond; S B Prusiner
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

View more
  10 in total

1.  Research on familial Creutzfeldt-Jakob disease (FCJD) resulting in presymptomatic testing: implications for the Human Genome Project.

Authors:  Janet E Ulm; Cindy L Vnencak-Jones; Patrick Bosque
Journal:  J Genet Couns       Date:  1993-03       Impact factor: 2.537

Review 2.  Molecular neurology of prion disease.

Authors:  J Collinge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

3.  Genetic counseling in a Swedish Alzheimer family with amyloid precursor protein mutation.

Authors:  L Lannfelt; K Axelman; L Lilius; H Basun
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

Review 4.  The DNA laboratory and neurological practice.

Authors:  A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-03       Impact factor: 10.154

5.  Molecular pathology of Alzheimer's disease.

Authors:  M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

6.  The genetic testing of children. Working Party of the Clinical Genetics Society (UK)

Authors:  A Clarke
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

Review 7.  Clinical genetics in neurological disease.

Authors:  J C MacMillan; P S Harper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-01       Impact factor: 10.154

8.  Inherited prion disease (PrP lysine 200) in Britain: two case reports.

Authors:  J Collinge; M S Palmer; T Campbell; K C Sidle; D Carroll; A Harding
Journal:  BMJ       Date:  1993-01-30

9.  Inherited Creutzfeldt-Jakob disease in a British family associated with a novel 144 base pair insertion of the prion protein gene.

Authors:  D Nicholl; O Windl; R de Silva; S Sawcer; M Dempster; J W Ironside; J P Estibeiro; G M Yuill; R Lathe; R G Will
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

10.  Altered DNA methylation profiles in blood from patients with sporadic Creutzfeldt-Jakob disease.

Authors:  Luke C Dabin; Fernando Guntoro; Tracy Campbell; Tony Bélicard; Adam R Smith; Rebecca G Smith; Rachel Raybould; Jonathan M Schott; Katie Lunnon; Peter Sarkies; John Collinge; Simon Mead; Emmanuelle Viré
Journal:  Acta Neuropathol       Date:  2020-09-12       Impact factor: 17.088

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.